New research reveals mismatched unrelated donors significantly improve transplant outcomes, expanding options for diverse patients in need of life-saving procedures.
Heather Stefanski, MD, PhD
Advertisement
Heather Stefanski, MD, PhD, is the vice president of CIBMTR and Clincal Services at NMDP.
Articles by Heather Stefanski, MD, PhD
The ACCESS study reveals that posttransplant cyclophosphamide improves survival rates for patients with mismatched unrelated donor transplants, expanding donor options.
Heather Stefanski, MD, PhD, discusses the unmet needs for patients undergoing bone marrow and stem cell transplants.
Advertisement
Latest Updated Articles
Challenging the "Perfect Match" Assumption for TransplantsPublished: December 8th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: Clinical Advancements and FDA News
2
Beyond Chemotherapy: Evaluating the Efficacy of Ribociclib, Letrozole in LGSOC
3
The Strategic Shift in SCLC Management: Bone Marrow Preservation
4
Relacorilant Demonstrates Significant OS in Platinum-Resistant Ovarian Cancer
5